Pharmaceutical Industry News
Bayer to boost Germany's COVID-19 analysis capacity by several thousand tests per day
Bayer is undertaking further measures to support the fight against the coronavirus pandemic. At various sites in Germany, the company is making available more than 40 virus diagnostics devices from its research operations, enabling Germany's COVID-19 analysis capacity to be increased by several thousand tests daily
Global Pharma | 31/03/2020 | By Darshana
FDA expedites review of diagnostic tests to combat COVID-19
The U.S. Food and Drug Administration has been providing unprecedented flexibility to labs and manufacturers to develop and offer COVID-19 tests across the U.S. The FDA?s regulations have not hindered or been a roadblock to the rollout of tests during this pandemic
Global Pharma | 31/03/2020 | By Darshana
Novartis and a consortium of life sciences companies announced an important collaboration to accelerate the development, manufacture and delivery of vaccines, diagnostics, and treatments for COVID-19 in response to the pandemic. The industry brings a range of assets, resources, and expertise needed to identify effective and scalable solutions
Global Pharma | 28/03/2020 | By Darshana
Genentech, a member of the Roche Group, announced the US Food & Drug Administration (FDA) has approved a randomized, double-blind, placebo-controlled phase III clinical trial in collaboration with the Biomedical Advanced Research and Development Authority (BARDA) to evaluate the safety and efficacy of intravenous Actemra (tocilizumab) plus standard
Global Pharma | 26/03/2020 | By Darshana
ADVANZ PHARMA Corp. Limited to Acquire Specialty Pharmaceutical Company Correvio Pharma Corp.
Advanz Pharma a global pharmaceutical company focused on serving the needs of patients and healthcare providers around the world with enhanced access to high quality, niche-established medicines, today announced that through its wholly-owned subsidiary, the Company has entered into an arrangement agreement dated March 15, 2020
Global Pharma | 17/03/2020 | By Darshana
ImmunoPrecise Introduces PolyTope mAb Therapy To Tackle Coronavirus Pandemic
IMMUNOPRECISE ANTIBODIES LTD, following its announcement to develop innovative treatments against the new coronavirus, SARS-CoV-2, unveils its unique approach utilizing PolyTope mAb Therapy™, enabled by IPA’s diverse discovery platforms and artificial intelligence capabilities with their partner, EVQLV, Inc., in the development of a universal COVID-19
Global Pharma | 15/03/2020 | By Darshana
Covid-19: Pharma companies ask Govt to lift API's export restrictions
Pharmaceutical lobby groups have urged the government to lift restrictions on export of active pharmaceutical ingredients (APIs) and formulations, saying they have enough stock and there will be no shortage of these formulations in India amid the coronavirus outbreak
Global Pharma | 12/03/2020 | By Darshana
Torrent Pharmaceuticals puts faith in local market, to focus on new drug launches
Torrent Pharmaceuticals is optimistic that the future of Indian drug makers is in the domestic market, as it looks at new launches in the lucrative chronic therapy areas
Global Pharma | 12/03/2020 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy